We report here an affinity-proteomics approach that combines 2D-gel electrophoresis and immunoblotting with high performance mass spectrometry to the identification of both full length protein antigens and antigenic fragments of Chlamydophila pneumoniae (C. pneumoniae). The present affinity-mass spectrometry approach effectively utilized high resolution FTICR mass spectrometry and LC-tandem-MS for protein identification, and enabled the identification of several new highly antigenic C. pneumoniae proteins that were not hitherto reported or previously detected only in other Chlamydia species, such as Chlamydia trachomatis. Moreover, high resolution affinity-MS provided the identification of several neo-antigenic protein fragments containing N-and C-terminal, and central domains such as fragments of the membrane protein Pmp21 and the secreted chlamydial proteasome-like factor (Cpaf), representing specific biomarker candidates.
Introduction
C . pneumoniae is an important human respiratory pathogen that causes approximately 5% of all cases of bronchitis and is believed to be responsible for about 10% of community-acquired pneumonia cases [I] . C. pneumoniae [uliana Susnea and Sebastian Bunk contributed equally to this work.
Correspondence 10: Michael Przybylsk i; e-mail: Michael.Przybylski@ un i-kol1stanz. de has a two-phase development cycle alternating between a metabolically inactive, but infectious form, elementary bodies (EB), and a noninfectious active fonn, reticulate bodies (RB) [I] . The bacterium uses human host cells for replication to which EB adhere and are phagocytosed 72 to 96 h post-infection in which time EB develop into RB [2] . C. pneumoniae persisting in the host following primary infection has been associated with atherosclerosis leading to cardiovascu lar diseases [3] . Albeit investigations for more than 15 y, the role of C. pneumoniae infection still remains controversial, with the lack of reproducible serodiagnosis being a major drawback [4] .
In previous studies, only limited molecular knowledge has been obtained about the immunodominant antigens in C. pneumoniae. The micro immunofluorescence (MIF) test, based on whole EB, has been employed as a standard for serology but presents several disadvantages such as cross-reactivity between different Chlamydia species and high interlaboratory variations [5] . Moreover, the MIF test does not correlate with the presence of C. pneumoniae in the host, nor differentiate between past and persistent infections [6] . A recent study on Chlamydia trachomatis by SanchezCampillo et al. employing an immunoproteomics approach, N-terminal sequencing and homology search provided the identification of a few immunoreactive proteins [7] . In a previous study, an affinity-proteomics approach combined with FTICR-MS with high specificity and reproducibility has been developed and applied for the identification of C. pneumoniae antigenic structures relevant for serodiagnosis [8] . The combination of 2-DE immunoproteomics with FTICR-MS and LC-MS/MS is shown here to be highly successful in identifYing several hitherto unknown antigens and, particularly, the identification of several neo-antigenic protein fragments. These results provide new and additional evidence for the specific description of biomarker candidates and design of possible therapeutic lead structures. 
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Experimental
2D-Gel Electrophoresis and lmmunoblotting
Sera from 39 human donors were tested for antibodies against C. pneumoniae, C. trachoma tis, and C. psittaci using the MIF assay (Savyon Diagnostics, St. Ashdod, Israel) [8] .
One serum tested positive for C. trachoma tis and was excluded from the study. C. pneumoniae TW-183 were cultured as previously described [8] .
Chlamydia samples were purified using the 2D Clean-up Kit (Amersham Biosciences, Uppsala, Sweden) and applied overnight on 17 cm IPG strips (PH range 3-10 NL) using a passive in-gel rehydration method, as described [8] . Following separation, proteins were visualized with sensitive colloidal Coomassie staining [9] , and gels were scanned with a Bio-Rad (Laboratories GmbH, Mlinchen, Germany) GS-710 imaging densitometer. All separations were perfonned in pairs of two gels, each run involving two electrophoretic cells, with three gels used for immunoblotting and one gel for mass spectrometric identification of antigenic proteins.
Following electrophoretic separation 20 gels were electroblotted for 2 h at 60 V onto nitrocellulose membranes using a WEB-M tank blotter (PEQLAB, Erlangen, Germany). Immunoblotting was performed as previously described [8] , and electronic image files matched with the 2DE maps ofthe Coomassie-stained gels. For the analysis of the immunoblots, the maximum intensity of each spot was determined using the AIDA software package (Ray test/Fuji, Straubenhardt, Germany) [8] .
Mass Spectrometry
Spots were excised from the gels, subjected to tryptic in-gel digestion according to [10] , and elution fractions desalted with Cl8 OMIX Pipette Tips (Varian, Walnut Creek, CA, USA.). MALDI-FTICR-MS peptide mapping was perfonned with a Bruker APEX II FTICR spectrometer equipped with an actively shielded 7T superconducting magnet (Bruker Daltonik, Bremen, Germany) as previously described [8] . Monoisotopic masses of singly charged ions generated by XMASS were directly used for database search [8] (http://www. matrixscience.com; and http://prowl.rockefeller.edu/).
LC-MS/MS analysis was perfonned on an Esquire 3000+ ion trap instrument (Bruker Daltonik) equipped with an atmospheric pressure ESI source, using nitrogen as both the nebulizing and drying gas. The instrument was operated in the data-dependent mode with MSMS acquisition upon a predetennined threshold; six microscans were collected at automatic gain control for each full MS scan and 20 microscans for each MS/MS scan, with a maximum accumulation time of 200 ms. An Agilent-ll00 HPLC was operated at 50 ilL/min, using binary elution of (A) (0.2% aqueous formic acid) to 55% (B) (0.2% formic acid in acetonitrile) over 90 min, with a 10 cm x 1 mm Discovery Bio Wide Pore C 18 column (Sigma-Aldrich Chemie GmbH, Mlinchen, Germany). MS data were externally calibrated and analysed using the Bruker Data Analysis 
Results and Discussion
Identification of C. pneumoniae Antigens by Immunoproteomics-Mass Spectrometry
C. pneurnoniae antigens were detected in four gels, processed in each 2DE run under identical conditions and subjected to immunoblotting and mass spectrometry. Approximately 600 protein spots were separated within a m.w. range of ca. 15 to 130 kDa (Supplementary Figure I) . Among the proteins visualised, 89 spots were detected as immunoreactive, and reactivities estimated based on corresponding intensities among all sera, as previously described [8] .
For identification of proteins, gel spots were excised, digested with trypsin, and the proteolytic peptides analyzed by MALDI-FTICR-MS and LC-tandem mass spectrometry. Initially, proteins from 42 spots showing consistent antigenic reactivity were examined. A total of22C. pneurnoniae proteins (from 28 protein spots) and six human proteins were identified (Supplementary Table I ). Human proteins, also found in previously reported proteome maps [2] , are likely resulting from contamination by the Hep-2 cells used in the C. pneurnoniae culture. Eight C. pneurnoniae proteins (from nine protein New proteins identified (not found in [8] ) of substantial antigenic reactivity are summarized in Table I (shown underlined and in red in the 2D-gel, Supplementary Figure I ). The application of LC-tandem-MS in the present study was found to effectively extend the previous MALDl-FTICR-MS data (Table I) 
Identification of Neo-antigenic Protein Fragments by High Resolution Affinity-Mass Spectrometry
In addition to several antigenic full length proteins, new, specific neo-antigenic protein fragments were identified in this study by affinity-proteomics using LC-MS/MS (Table 2) .
Two polymorphic membrane proteins, Pmp6 and Pmp21, that contain an autotransporter domain and thus can pass the outer bacterial membrane, were identified both as full length proteins and as specific truncation forms. Protein spot 45 of ca. 130 kDa was identified as full length Pmp6 ( [8] ), and in the present study as a 60 kDa C-terminal fragment (spot 35) with high antigenic reactivity. For Pmp21 , the largest of the 21 polymorphic C. pneurnoniae membrane proteins, three 787 fragments were identified with molecular mass es of ca. 70, 55, and 45 kDa, respectively, representing an N-terminal fragment (Pmp21 -n; spot 36), a middle domain fragment (Pmp21 -m; spot 9), and a C-terminal fragment (Pmp21 -c; spot 10). With purified RB, no C-terminal Pmp21 fragment was found , while in purified EB only a 47 kDa C-terminal fragment has been previously identified [2, 11] . In contrast, the present combination approach of immunoblotting and high resolution mass spectrometry provided the unequivocal identification of all three Pmp21 fragments ( Table 2) .
The chlamydial protease/proteasome-like activity factor, Cpaf was identified as a further example where only neoantigenic fragments were isolated by 2-DE and identified ( Table 2) . Only a few secreted proteins have been hitherto identified for C. pneurnoniae. In the present study, we identified both a C-and N-terminal antigenic fragment: a basic 24 kDa fragment (Cpaf-n; pI 7) .and an acidic ca. 40 kDa fragment (PI 5; Cpaf-c). The latter fragment had not been previously detected [12] , possibly due to its comigration with the RpoA protein (Spot 14, Supplementary Figure I ). 
Conclusion
In this study, an affinity-proteomics approach in combination with high performance mass spectrometry, MALDl -FTICR-MS, and LC-MS/MS demonstrated as an efficient tool to identify antigenic structures of C. pneurnoniae relevant for serodiagnosis. In addition to previously described C. pneurnoniae proteins, seven new reactive proteins were identified here (Table 1) , which may represent specific biomarkers for C. pneurnoniae infections. High resolution affinity-mass spectrometry proved to be a particularly efficient tool for the identification of neoantigenic protein fragments of two proteins, the full length precursor proteins of which lack antigenicity, the membrane protein Pmp21, and the chlamydial proteasome like-activity factor Cpaf (Table 2) . Thus, the highly antigenic proteins identified here should be useful to (1), enable the development of more standardized serodiagnosis techniques capable to discriminate between past and persistent infections; (2), clarify the role of C. pneurnoniae in chronic inflammatory diseases; and (3), establish biomarker candidates for future drug development.
